Amag Pharmaceuticals (AMAG)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2014 | 03-2014 | 12-2013 | 09-2013 | 06-2013 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 202,057 | 200,916 | 26,986 | 30,946 | 27,802 |
| Marketable Securities | 184,416 | 184,557 | 186,803 | 182,595 | 184,611 |
| Receivables | 10,811 | 10,317 | 7,120 | 9,028 | 8,858 |
| Inventories | 21,969 | 20,804 | 17,217 | 14,694 | 13,474 |
| Other current assets | 0 | 0 | 2,883 | 2,394 | 2,394 |
| TOTAL | $424,074 | $421,004 | $244,405 | $245,557 | $242,797 |
| Non-Current Assets | |||||
| PPE Net | 1,706 | 1,837 | 1,846 | 1,741 | 1,913 |
| Intangibles | 16,740 | 16,815 | 16,844 | 16,866 | 17,192 |
| Other Non-Current Assets | 6,326 | 6,807 | 2,364 | 400 | 400 |
| TOTAL | $24,772 | $25,459 | $21,054 | $19,007 | $19,505 |
| Total Assets | $448,846 | $446,463 | $265,459 | $264,564 | $262,302 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 3,525 | 5,125 | 2,629 | 1,001 | 2,443 |
| Accrued Expenses | 24,446 | 21,851 | 22,266 | 20,032 | 18,256 |
| TOTAL | $37,193 | $36,094 | $33,121 | $31,060 | $29,968 |
| Non-Current Liabilities | |||||
| Deferred Revenues | 9,222 | 9,118 | 8,226 | 10,027 | 9,269 |
| Other Non-Current Liabilities | 180,307 | 178,706 | 15,396 | 14,825 | 14,850 |
| TOTAL | $218,667 | $219,273 | $59,930 | $59,253 | $61,252 |
| Total Liabilities | $255,860 | $255,367 | $93,051 | $90,313 | $91,220 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 21,958 | 21,915 | 21,800 | 21,736 | 21,687 |
| Common Shares | 220 | 219 | 218 | 217 | 217 |
| Retained earnings | -474,909 | -473,362 | -466,260 | -462,606 | -462,461 |
| Other shareholders' equity | -3,259 | -3,414 | -3,491 | -3,536 | -3,935 |
| TOTAL | $192,986 | $191,096 | $172,408 | $174,251 | $171,082 |
| Total Liabilities And Equity | $448,846 | $446,463 | $265,459 | $264,564 | $262,302 |